Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Rapid Micro Biosystems, Inc. (RPID) Insider Trading Activity
Healthcare • Medical Devices • 193 employees
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
Total Value
$183,025.81
Total Shares
215,000
Average Trade Value
$22,878.23
Most Active Insider
Kollender Richard S
Total Activity: $50,128
Largest Single Transaction
$50,128
by Kollender Richard S on Aug 6, 2024
30-Day Activity
3 Transactions
Volume: 39,892 shares
Value: $41,250
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Director
|
Dec 5, 2024 | 9,120 | $9,484 | 54,300 (+16.8%) | Purchase | |
Director
|
Dec 3, 2024 | 10,880 | $10,880 | 45,180 (+24.1%) | Purchase | |
Director
|
Nov 27, 2024 | 19,892 | $20,887 | 34,300 (+58.0%) | Purchase | |
Director
|
Nov 26, 2024 | 108 | $112 | 14,408 (+0.7%) | Purchase | |
Director
|
Aug 8, 2024 | 50,000 | $45,335 | 64,300 (+77.8%) | Purchase | |
Chief Financial Officer
Officer
|
Aug 7, 2024 | 10,000 | $7,800 | 348,157 (+2.9%) | Purchase | |
President and CEO
Director, Officer
|
Aug 6, 2024 | 50,000 | $38,400 | 540,012 (+9.3%) | Purchase | |
Director
|
Aug 6, 2024 | 65,000 | $50,128 | 96,718 (+67.2%) | Purchase |